Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Sano, Masaki ^a,b   Sasaki, Takeshi ^a   Hirakawa, Satoshi ^a   Sakabe, Junichi ^a   Ogawa, Mikako ^a   Baba, Satoshi ^b   Zaima, Nobuhiro ^b,c   Tanaka, Hiroki ^a,b   Inuzuka, Kazunori ^a,b   Yamamoto, Naoto ^a,b   Setou, Mitsutoshi ^b   Sato, Kohji ^a   Konno, Hiroyuki ^b   Unno, Naoki ^a,b  

^a Division of Vascular Surgery Applied Medical Photonics Laboratory Medical Photonics Research Center ^*  (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; PODOPLANIN; RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN C; HIF1A PROTEIN, HUMAN;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ADVENTITIA; AGED; ANEURYSM SURGERY; ANGIOGENESIS; AORTA INTIMA; AORTA MEDIA; ARTICLE; AUTOPSY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPH; LYMPHANGIOGENESIS; LYMPHOGRAPHY; MACROPHAGE; MALE; MICROVASCULATURE; MORPHOMETRICS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASA VASORUM; CASE CONTROL STUDY; CELL MOTION; COMPLICATION; INFLAMMATION; INTIMA; LYMPH VESSEL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; AORTIC ANEURYSM, ABDOMINAL; CASE-CONTROL STUDIES; CELL MOVEMENT; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; LYMPHOGRAPHY; MALE; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; TUNICA INTIMA;

EID: 84902151973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089830     Document Type: Article

References (52)

1. Baxter BT, Terrin MC, Dalman RL (2008) Medical management of small abdominal aortic aneurysms. Circulation 117: 1883-1889. (Pubitemid 351507477)
2. Kajimoto K, Miyauchi K, Kasai T, Shimada K, Kojima Y, et al. (2009) Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis 206: 505-511.
3. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R (2009) Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 119: 2209-2216.
4. Bruemmer D, Collins AR, Noh G, Wang W, Territo M, et al. (2003) Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 112: 1318-1331. (Pubitemid 38057686)
5. Tanaka H, Zaima N, Sasaki T, Hayasaka T, Goto-Inoue N, et al. (2013) Adventitial vasa vasorum arteriosclerosis in abdominal aortic aneurysm. PLoS One 8: e57398.
6. Holmes DR, Liao S, Parks WC, Thompson RW (1995) Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg 21: 761-771; discussion 771-762.
7. Swedenborg J, Mayranpaa MI, Kovanen PT (2011) Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 31: 734-740.
8. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, et al. (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115: 247-257. (Pubitemid 40385467)
9. Danese S, Sans M, de la Motte C, Graziani C, West G, et al. (2006) Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130: 2060-2073. (Pubitemid 43816964)
10. Thairu N, Kiriakidis S, Dawson P, Paleolog E (2011) Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Angiogenesis 14: 223-234.
11. Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S (2001) Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 21: 2351-2355. (Pubitemid 33054395)
12. Nakayama Y, Matsumoto K, Nagato M, Inoue Y, Katsuki T, et al. (2007) Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma. Anticancer Res 27: 619-625. (Pubitemid 46374986)
13. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8.
14. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, et al. (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177: 275-283.
15. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, et al. (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484.
16. Unno N, Nishiyama M, Suzuki M, Yamamoto N, Inuzuka K, et al. (2008) Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Vasc Endovasc Surg 36: 230-236. (Pubitemid 351952341)
17. Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193.
18. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. (Pubitemid 351818697)
19. Drozdz K, Janczak D, Dziegiel P, Podhorska M, Piotrowska A, et al. (2012) Adventitial lymphatics and atherosclerosis. Lymphology 45: 26-33.
20. Ordonez NG (2012) Immunohistochemical endothelial markers: a review. Adv Anat Pathol 19: 281-295.
21. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, et al. (2005) Upregulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166: 913-921. (Pubitemid 40315647)
22. Hatakeyama K, Kaneko MK, Kato Y, Ishikawa T, Nishihira K, et al. (2012) Podoplanin expression in advanced atherosclerotic lesions of human aortas. Thromb Res.
23. Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, et al. (2006) Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 209: 67-77.
24. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, et al. (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113: 1040-1050. (Pubitemid 38544126)
25. Kerjaschki D (2005) The crucial role of macrophages in lymphangiogenesis. J Clin Invest 115: 2316-2319.
26. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, et al. (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115: 2363-2372. (Pubitemid 41266198)
27. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, et al. (2006) Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12: 230-234. (Pubitemid 43214751)
28. Vorp DA, Lee PC, Wang DH, Makaroun MS, Nemoto EM, et al. (2001) Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 34: 291-299. (Pubitemid 33661127)
29. Tammela T, Enholm B, Alitalo K, Paavonen K (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65: 550-563. (Pubitemid 40138976)
30. Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, et al. (2011) Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm. Cardiovasc Res 91: 358-367.
31. Rizas KD, Ippagunta N, Tilson MD 3rd (2009) Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol Rev 17: 201-210.
32. Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 295: 369-377.
33. Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 295: 420-425.
34. Fenyo IM, Gafencu AV (2013) The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. Immunobiology 218: 1376-1384.
35. Stoger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, et al. (2012) Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225: 461-468.
36. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, et al. (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167: 570-581. (Pubitemid 18073655)
37. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189. (Pubitemid 38174573)
38. Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313-326.
39. Choi I, Lee YS, Chung HK, Choi D, Ecoiffier T, et al. (2013) Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration. Angiogenesis 16: 29-44.
40. Shi VY, Bao L, Chan LS (2012) Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4-transgenic mouse model. Microcirculation 19: 567-579.
41. Suzuki Y, Ito Y, Mizuno M, Kinashi H, Sawai A, et al. (2012) Transforming growth factor-beta induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int 81: 865-879.
42. James JM, Nalbandian A, Mukouyama YS (2013) TGFbeta signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin. Development 140: 3903-3914.
43. Sharma R, Wendt JA, Rasmussen JC, Adams KE, Marshall MV, et al. (2008) New horizons for imaging lymphatic function. Ann N Y Acad Sci 1131: 13-36. (Pubitemid 351758500)
44. Unno N, Yamamoto N, Suzuki M, Tanaka H, Mano Y, et al. (2013) Intraoperative lymph mapping with preoperative vein mapping to prevent postoperative lymphorrhea following paramalleolar bypass surgery in patients with critical limb ischemia. Surg Today.
45. Sugaya M, Kuwano Y, Suga H, Miyagaki T, Ohmatsu H, et al. (2012) Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens. J Invest Dermatol 132: 667-676.
46. Zampell JC, Aschen S, Weitman ES, Yan A, Elhadad S, et al. (2012) Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg 129: 825-834.
47. Xu X, Lu H, Lin H, Ni M, Sun H, et al. (2009) Lymphangiogenesis promotes inflammation and neointimal hyperplasia after adventitia removal in the rat carotid artery. Int J Cardiol 134: 426-427.
48. Zampell JC, Yan A, Elhadad S, Avraham T, Weitman E, et al. (2012) CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLoS One 7: e49940.
49. Miwa K, Nakashima H, Aoki M, Miyake T, Kawasaki T, et al. (2005) Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Ther 12: 1109-1118. (Pubitemid 41030616)
50. Vijaynagar B, Bown MJ, Sayers RD, Choke E (2013) Potential role for anti-angiogenic therapy in abdominal aortic aneurysms. Eur J Clin Invest 43: 758-765.
51. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170: 1178-1191. (Pubitemid 47339326)
52. Zhou Q, Guo R, Wood R, Boyce BF, Liang Q, et al. (2011) Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. Arthritis Rheum 63: 2318-2328.